The NPKUA is pleased to highlight the 2014 Research Awards. These awards are made possible by our member organizations who raise funds each year on the local level for research. Thank you for helping make these awards possible as we work towards improving treatment options for PKU and accelerating the timeline for a cure.

The overall funding strategy of the NPKUA is to support projects that will promote advances in the treatment and management of PKU, with the long term goal of facilitating the development of a cure. The NPKUA has a Scientific Advisory Board made up of eminently qualified doctors, researchers and clinicians that evaluate the proposals and provide a recommendation to the NPKUA Board each year for funding.

The last five years have seen great strides in finding ways to improve treatment for PKU. We are pleased to share our annually funded research awards that focus on new and innovative treatment options for PKU and accelerating the timeline for a cure.

Click here for a list of the 2010
Research Awards.

Click here for a list of the 2011
Research Awards.

Click here for a list of the 2012
Research Awards.

Click here for a list of the 2013
Research Awards.

Click here for a list of the 2014
Research Awards.

2014 Research Awards

Dr. Shawn Christ, Associate Professor of Psychological Sciences and Associate Director of the Brain Imaging Center at the University of Missouri, will examine the effects of PKU on gray matter structures in the brain.

Dr. Donna Santillan, and her lab at the University of Iowa Hospitals and Clinics, have been developing an artificial organ system by encapsulating HepG2 cells to treat PKU.

Dr. Kristen Skvorak, at the University of Pittsburgh Medical Center, will continue to research in the PKU mouse model with hepatocytes, liver cell transplantatisms, and will also begin in-vestigations of alternate sources of cells for transplant, in particular human amnion epithelial cells (hAE).

Dr. Eddy van derZee, is the Chair of Molecular Neurobiology at the University of Groningen, Nether-lands. Dr. van der Zee will study the liberalization of dietary restric-tions in PKU using LNAA supple-mentation in PKU mice.

Dr. Michael Allen, Associate Professor in the Dept. of Forensic and Investigative Genetics at the University of North Texas Health Science Center will look at the effect of PKU on the gut micro-biome and its implications for probiotic therapy.

Click here for full summaries of the 2014 research projects.